Switch to:
Biomarin Pharmaceutical, Inc. (NAS:BMRN)
EV/EBITDA
-73.01 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Biomarin Pharmaceutical, Inc.'s enterprise value is $8,616.1 Mil. Biomarin Pharmaceutical, Inc.'s earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Dec. 2013 was $-118.8 Mil. Therefore, Biomarin Pharmaceutical, Inc.'s EV/EBITDA ratio for today is -73.01.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Biomarin Pharmaceutical, Inc.'s stock price is $60.89. Biomarin Pharmaceutical, Inc.'s earnings per share for the trailing twelve months (TTM) ended in Dec. 2013 was $-1.28. Therefore, Biomarin Pharmaceutical, Inc.'s P/E Ratio for today is 0.00.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Biomarin Pharmaceutical, Inc.'s EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=8616.061/-118.792
=

Biomarin Pharmaceutical, Inc.'s current Enterprise Value is $8,616.1 Mil.
Biomarin Pharmaceutical, Inc.'s Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Dec. 2013 was -31.232 (Mar. 2013 ) + -6.747 (Jun. 2013 ) + -38.415 (Sep. 2013 ) + -42.398 (Dec. 2013 ) = $-118.8 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Biomarin Pharmaceutical, Inc.'s P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=60.89/-1.284
=

Biomarin Pharmaceutical, Inc.'s share price for today is $60.89.
Biomarin Pharmaceutical, Inc.'s Earnings Per Share for the trailing twelve months (TTM) ended in Dec. 2013 was -0.31 (Mar. 2013 ) + -0.16 (Jun. 2013 ) + -0.38 (Sep. 2013 ) + -0.434 (Dec. 2013 ) = $-1.28.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Biomarin Pharmaceutical, Inc. Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebitda 24.1241.3636.55112.4226.4758.82180.644,674.710.000.00

Biomarin Pharmaceutical, Inc. Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
ev2ebitda 958.214,674.710.000.000.000.000.000.000.000.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide